Key Drivers
- Profit Rebound
- Cash Flow Strength
- Rising Liabilities
AIAI Summary
CLOV has shifted from a distressed turnaround to a credible growth-and-profitability story after posting rapid revenue/member growth, GAAP profitability, and strong cash generation with no debt, but the key investment question now is whether it can sustain that narrow margin improvement without execution or medical-cost slippage as the stock already prices in much of the good news.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profit Rebound
- •Cash Flow Strength
- •Rising Liabilities
CLOV delivered a strong Q1 2026 turnaround with $749.2M revenue, positive earnings, and solid free cash flow, but higher liabilities and a large accumulated deficit keep the risk profile elevated.
Price Behavior
Key Price Behavior Insights:
- •Breakout Hold
- •Overbought Risk
- •Rising Volatility
CLOV shows strong bullish momentum over the last month, breaking above prior congestion and holding gains, but the move looks stretched and may need a pullback unless it clears $3.55.
Fast, bursty climb from $2.19 to $3.47 over the last month suggests short-term volatility risk
Sentiment & News
Key News Insights:
- •Revenue Surge
- •Membership Growth
- •GAAP Profitability
Clover Health posted a strong Q1 with 62% revenue growth, 51% Medicare Advantage membership gains, and improving profitability while reaffirming a positive 2026 outlook.
The results are bullish for CLOV, signaling accelerating scale, improving margins, and stronger confidence in full-year execution
Similar Companies in Healthcare
Other companies in the same sector with AI ratings